A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Phase 4 Completed 261 enrolled Xian-Janssen Pharmaceutical Ltd.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the impact of escitalopram on quality of life and social functionality in patients with major depressive disorder with anxiety symptom.

Timeline

Start: 2014-03
Primary completion: 2015-05
Completion: 2015-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Escitalopram	Small molecule	20 mg	Oral

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Summary

Timeline

Drugs

Indications